Typbar Typhoid Conjugate Vaccine

Bharat Biotech’s Typbar TCV, the world’s first clinically proven typhoid conjugate vaccine, has received pre-qualification from the World Health Organisation (WHO).  It is the fourth generation vaccine against typhoid, proven to provide long-term protection to adults and infants – six months and older.